Oxford Cancer Analytics
ActiveAI-nativeEnabling Curative Cancer Treatment Through Early Detection- Focused on Lung Cancer
What it does
Oxford Cancer Analytics is transforming curative cancer treatments through a minimally invasive blood test and machine learning. We are focused on lung cancer Oxford Cancer Analytics focuses on strategic beachhead markets in lung cancer for expedited product deployment. Applying state-of-the-art machine learning for multidimensional liquid biopsy data with a focus on protein enables maximised detection accuracy compared to leading competitors. OXcan has international partnerships focusing on all aspects of lung cancer management, from high risk screening, to early recurrence detection and personalised treatment stratification.
Its site says now · captured 2026-08-23
OXcan | Oxford Cancer Analytics
Transforming Lung Disease with a Single Blood Test
Next to it in Healthcare and bio · AI-powered lung cancer early detection
- Twinn Health500 Global 500G Mena 2
Developer of healthcare tools intended for early disease detection using imaging and AI tools to extend a healthy human lifespan. The company's platform uses MRI scanning and AI to get information about metabolism and body composition, enabling healthcare professionals to look for warning signs of potential inflammation, damage, and disease in major organs, muscles, and bones.
- Deep BreathePlug and Play PnP 2024
Deep Breathe is lung ultrasound and deep learning medical technology company.
- Axiom TherapeuticsPlug and Play PnP 2025
AI-powered covalent drug discovery for untreatable cancers
- Inixi BioSOSV SOSV IBSF 25H2 2025
Stopping cancer at stage zero
- Asima Health Inc.Plug and Play PnP 2024
World's fastest, simplest and cheapest pan-cancer screening platform.
- KlinriskPlug and Play PnP 2024
Klinrisk finds progressive kidney disease early before kidney function is lost
- Rya HealthPlug and Play PnP 2024
A New Healthcare Experience For Patients and Providers
- Amplified SciencesPlug and Play PnP 2025
Amplified Sciences is a life science diagnostics company focusing on detecting and pre-empting the risks of debilitating diseases.